Skip to content

Medilax-N

by Ioulia and Irene Tseti Pharmaceutical Laboratories S.A. Greece EUDAMED

Ref MEDILAX-N Model MEDILAX-N 3g

EMDN G99

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-MDLXMD77013M8 Basic UDI-DIDate1 May 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
MEDILAX-N 3g, MEDILAX-N
Primary DI / UDI-DI
D-MDLXMD77013M8
Basic UDI-DI
B-MDLXMD77013M8
EMDN Code
G99 Gastrointestinal devices - other
Device Class
Class I
Market of Registration
Greece

Manufacturer details

EUDAMED SRN
GR-MF-000032958

Other devices from Ioulia and Irene Tseti Pharmaceutical Laboratories S.A.

See all devices from Ioulia and Irene Tseti Pharmaceutical Laboratories S.A. →

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED ff650bf4-9deb-4cc4-b283-79fd0e81a00c 61 fields · synced 22 Oct 2026